Table 2.
Inhibitors of protein targets in the insulin signaling pathways, studied via molecular docking, and their plausible binding sites.
Protein | Inhibitors found using docking experiments | Interaction used AA residues |
---|---|---|
Insulin receptor and PTP-1β | IR: herbacetin and sorbifolin [120] IR: ANP [129] PTP1β: secoisoresinol, pinoresinol, cedeodarin, and UN608 [129] PTP1B: CYC31 [109] PTP1B: carainterol A [110] |
IR-PTP1β: Tyr48, and His110 [120] IR: Leu1002, Met1079, and Asp1150 [120] PTP1β: Ser1006, Lys1030, Asp1083, Met1079, and Glu1077 [129] PTP1B: Ala217, Arg221, Gly183, and Gln266 [109] |
| ||
PI3K signaling proteins | PDK1-PI3K: myricetin, quercetin, morin, luteolin, and emodin [138] Akt: sulforaphane and curcumin [138] PIK3-Akt: carainterol A [110] Akt1: 6-0-feruloyl catalpol, 5,7-dihydroxy-8-(3-methyl-2-butenyl) coumarin, isobutrin, MBH-4-flouroracemic, irigenin, junipeginin C, 5,7,4′-trihydroxyflavone-3-O-glucuronide, and ovalitenone [185]. Akt1: 3,5-trisubstituted pyridines, 5-pyrrolopyridinyl-2-thiophenecarboxamides, pyrrolopyrimidine, dihydrothieno and dihydrofuropyrimidines, and isoquinoline–pyridine with oxindole–pyridine derivatives [185]. Akt1: quercetin-7-O-β-D-glucopyranoside [200]. Akt-MTOR: 6-methylheptyl sulfate, aegelinol, 2-hydroxynephthenol, iodocionin, (Z)-oct-5-enyl sulfate, osthol [53] Akt: vemurafenib [148]. MTOR: riboflavin [148]. PI3K-Akt-MTOR: wotmannin, MK-2206, LY-294002, mitoxantrone, and rapamycin [148]. Akt1: hesperetin [171] |
PDK1: Leu88, Leu159, Ala109, Val143, Tyr161, Ala162, Ala162, Leu212, Ser160, Glu209, and Thr222 [138] PIK3: Pro810, Trp812, Tyr867, Ile 881, Val882, Ala885, Ile879, met 953, and Phe961 [138] Akt1: Leu156, Val164, Ala177, Met227, Tyr229, Ala230, Phe236, Phe237, Met281, Tyr437, Phe438, and Phe442; polar Thr211, Asp279, Thr291, Thr435, and Thr443 residues; negatively charged Glu228, Glu234, Glu278, Asp292, and Asp439 residues; positively charged Lys158, Lys179, and Arg241 [185]. Akt: Ala230, Glu226, Glu234, Tyr272, Val164, Ala177, Ilu800, Thr291, and Met28 [148] MTOR: Val882 and Lys890 [148]. Akt1: Gln79, Thr211, and Leu210 [171]. PI3Kα site A: Lys802, Asp810, Asp933, and Val851 [152]. PI3Kα site B: Val851 and Gln859 [152]. PI3Kγ site A: Lys833 [152]. PI3Kγ site B: Lys833 and ASP844 [152]. PI3K–C2β: Val1115 [152]. P70S6K1: Glu143 and Lys123 [152]. mTOR site A: Lys-asp pair [152] mTOR site B, backbone nucleotide loop [152]. PI3Kγ: Met804, Ser806, Trp812, Ile831, Lys833, Tyr867, Ile879, Asp950, Asn951, Met953, Ile963, and Asp964 [159]. Akt: Residues Leu156, Gly157, Val164, Ala177, Thr211, Met227, Glu228, Ala230, Glu234, Met281, Thr291, Asp292, Phe438, and Phe442 [159]. mTOR:: Leu2185, Glu2190, Asp2195, Tyr2225, Ile2237, Gly2238, Trp2239, Val2240, Met2345, Ile2356, and Asp2357 [159]. PI3K: His39, Phe87, Phe88, Phe111, Phe112, Asn114, Met115, Phe116, Tyr166, Arg170, Tyr184, Asp185, Val186, Leu187, Gln203, Leu206, Lys210, Phe211, Trp259, Gly260, Tyr262, His263, Phe265, Ser266, Leu267, Glu269, Ala270, Trp283, Leu286, Pro287, Phe288, Val289, Thr290, Ser291, Leu292, and Ala293 Phe294 [219]. Akt: Ser205 [223] |
| ||
Further proteins effecting insulin signaling | RAC1: subsets of flavonoids, morpholines, and imidazoles [251] RAC1-HSP90-EGFR-CDH1-COPS2: rhein [259] SRAC1: 4F rhein derivative, NSC23766 [274] |
RAC1: Asp65-arg-66-Arg68-Pro69 and Ala95-lys96-pro99-glu100-his103-his104 [251]. |
| ||
PTEN | Naringin [279] | Cys124, Arg130, His93, Gly127, Asp92, Gln171, Ala126, Lys125, and Lys 128 [287]. Tyr16, Asp24, Arg47, Gly44, Val45, Asp92, His93, Ala126, Lys128, Asp162, Lys164, Asp326, Lys330.Tyr16, Val45, Asp92, and Ala126 [299]. Tyr16, Val45, Ala126, and Asp92 [300]. |
| ||
GLUT4 | Stigmasterol glucoside [301]. N-(3-(3-(4-Fluorophenyl)propyl)benzyl-3-(2-methoxyphenyl)-N-pyridin-4-ylmethyl)propanamide and (3-((3-((methyl((quinolin-6-ylmethyl)amino)methyl)phenoxy)methyl)piperidin-1-yl) (1,4,5,6-tetrahydrocyclopenta[c]pyrazol-3-yl)methanone [312] |
Gln439, Ala86, Ile184, Asn431, Phe88, Ile42, Tyr308, Val85, Ala86, and Ile184 [301]. Leu185, Ile42, Phe307, Asn427, Asn176, and Trp404 [312]. Ile42, Leu185, Phe38, Phe307, Asn427, and Trp404 [312]. |